Major medical associations remain silent after the results of a four-year review commissioned by the National Health Service England undermined their recommendations for giving puberty blockers to children with gender dysphoria.
The Cass Report, conducted by Dr. Hilary Cass, a pediatrician and former president of the U.K.’s Royal College of Pediatrics and Child Health, found only“weak evidence” for offering puberty blockers to children.
Cass concluded that her findings, released April 10, “raise questions about the quality of currently available guidelines” offered by associations such as the World Professional Association for Transgender Health and the Endocrine Society, yet neither organization has committed to reviewing their guidelines.
The review recommends against treating children with puberty blockers outside of a research setting. It also…
